Hollencrest Capital Management

Source: SEC Form 13F · as of Mar 2026

Hollencrest Capital Management holds 55 biotech & pharma companies tracked by BioSniper, totaling $65.4M in value as of Mar 2026 (SEC Form 13F).

Companies held

55

Total value held

$65.4M

CompanySharesValue
UNHUnitedHealth Group Incorporated Common Stock (DE)135,849$36.8M
PMPhilip Morris International Inc108,317$17.9M
JNJJOHNSON & JOHNSON15,204$3.7M
AMGNAMGEN INC4,073$1.4M
ABBVAbbVie Inc.6,287$1.4M
LLYELI LILLY & Co868$799K
MRKMerck & Co., Inc.4,777$575K
GMOptec International, Inc.7,200$536K
DVADaVita Inc.2,789$429K
MCKMcKesson Corporation400$346K
HLFHerbalife Ltd.17,100$252K
ABTABBOTT LABORATORIES1,561$160K
ICUIICU Medical Inc.1,125$145K
DFTXDefinium Therapeutics Inc.7,386$140K
VTRSViatris Inc9,568$129K
GILDGILEAD SCIENCES, INC.822$115K
NVONovo Nordisk A/S2,341$86K
CRSPCRISPR Therapeutics AG1,312$62K
NTLAIntellia Therapeutics, Inc.3,828$49K
OPKOPKO HEALTH, INC.40,000$46K
BEAMBeam Therapeutics Inc.1,807$43K
GHGuardant Health Inc.445$41K
CAHCardinal Health Inc.193$41K
AXSMAxsome Therapeutics, Inc.200$34K
GMEDGlobus Medical Inc.294$25K
PFEPFIZER INC863$24K
ACADACADIA PHARMACEUTICALS INC1,000$22K
RIOTRiot Platforms, Inc.1,765$22K
NVSNovartis AG132$20K
BMYBRISTOL MYERS SQUIBB CO305$18K
GEHCGE HealthCare Technologies Inc.199$14K
AQSTAquestive Therapeutics, Inc.3,000$12K
VRTXVERTEX PHARMACEUTICALS INC / MA16$7K
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)117$6K
REGNREGENERON PHARMACEUTICALS, INC.7$5K
ZTSZoetis Inc.44$5K
PTGXProtagonist Therapeutics, Inc45$5K
ZBHZimmer Biomet Holdings Inc.50$5K
SUPNSUPERNUS PHARMACEUTICALS, INC.80$4K
ELVElevance Health Inc.14$4K
ROIVRoivant Sciences Ltd.140$4K
ANABANAPTYSBIO, INC50$3K
CORCencora Inc.8$3K
BIIBBIOGEN INC.13$2K
OGNOrganon & Co.386$2K
BAXBaxter International Inc.109$2K
BMRABIOMERICA INC825$2K
CRONCronos Group Inc.575$1K
ACBAURORA CANNABIS INC350$1K
EDITEditas Medicine, Inc.400$988
IQVIQVIA Holdings Inc.4$682
DNAGinkgo Bioworks Holdings Inc.75$460
ALNYALNYLAM PHARMACEUTICALS, INC.1$331
MDXGMiMedx Group Inc15$59
SNDLSNDL Inc.5$7

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Hollencrest Capital Management — Biotech 13F Holdings & Portfolio | BioSniper